Literature DB >> 32829080

Health-Related Quality-of-Life Comparison of Adult Related and Unrelated HSC Donors: An RDSafe Study.

Galen E Switzer1, Jessica G Bruce2, Deidre M Kiefer3, Hati Kobusingye3, Kaleab Z Abebe4, Rebecca Drexler3, RaeAnne M Besser3, Dennis L Confer3, Mary M Horowitz5, Roberta J King3, Bronwen E Shaw5, Marcie Riches6, Brandon Hayes-Lattin7, Michael Linenberger8, Brian Bolwell9, Scott D Rowley10, Mark R Litzow11, Michael A Pulsipher12.   

Abstract

Multiple investigations have documented the health-related quality-of-life (HRQoL) and donation-related experiences of unrelated donors (URDs), but similar investigations of the related donor (RD) experience have been less common. The central goal of this study was to longitudinally examine and compare HRQoL of RD and URD hematopoietic stem cell (HSC) donors from predonation through 1 year postdonation. This prospective investigation included adult HSC donors ages 18 to 60 years who donated bone marrow or peripheral blood stem cells at one of 48 geographically diverse US transplant/donor centers and completed HRQoL interviews at predonation and 4 weeks and 1 year postdonation. At predonation, related donors were less ambivalent about donation (t = -3.30; P = .001), more satisfied with their decision to donate (t = 2.65; P = .009), and more likely to define themselves as donors (t = 2.94; P = .004) than were URDs. However, related donors were more concerned about the use of needles (odds ratio [OR] = 2.19; P = .012), about who would pay for the procedure (OR = 2.80; P = .011), and the possibility that they would feel responsible if the transplant failed (t = 2.31; P = .022). Shortly postdonation, related donors were more likely to report donation-related pain (t = 2.50; P = .013) and lightheadedness (OR = 3.63; P = .028). At 1 year postdonation, related donors were less likely to be fully recovered from donation (OR = 0.10; P = .010) and more likely to report a longer recovery period following donation (t = 2.57; P = .011), although this latter finding was primarily due to the percentage of related versus unrelated donors not fully recovered at 1 year postdonation (10% versus 1%). Taken together, these findings suggest that current related donor management practices may be sufficient in preparing related donors for the psychological aspects of donation but that there may be more to do in terms of calibrating the description of donation-related experiences and recovery time to the related donor group (i.e., descriptions of donation experiences based on unrelated donation may not provide best estimates of experience for this group).
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  HSC donation; HSC donor HRQoL; Related versus unrelated donation

Mesh:

Year:  2020        PMID: 32829080      PMCID: PMC7686016          DOI: 10.1016/j.bbmt.2020.08.016

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  21 in total

1.  Hematopoietic stem cell transplantation: a global perspective.

Authors:  Alois Gratwohl; Helen Baldomero; Mahmoud Aljurf; Marcelo C Pasquini; Luis Fernando Bouzas; Ayami Yoshimi; Jeff Szer; Jeff Lipton; Alvin Schwendener; Michael Gratwohl; Karl Frauendorfer; Dietger Niederwieser; Mary Horowitz; Yoshihisa Kodera
Journal:  JAMA       Date:  2010-04-28       Impact factor: 56.272

2.  Factors associated with attrition from a national bone marrow registry.

Authors:  G E Switzer; M A Dew; A A Stukas; J M Goycoolea; J Hegland; R G Simmons
Journal:  Bone Marrow Transplant       Date:  1999-08       Impact factor: 5.483

3.  Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Recovery of Unrelated Donors of Bone Marrow: A Prespecified Analysis from the Phase III Blood and Marrow Transplant Clinical Trials Network Protocol 0201.

Authors:  Linda J Burns; Brent R Logan; Pintip Chitphakdithai; John P Miller; Rebecca Drexler; Stephen Spellman; Galen E Switzer; John R Wingard; Claudio Anasetti; Dennis L Confer
Journal:  Biol Blood Marrow Transplant       Date:  2016-03-21       Impact factor: 5.742

4.  Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors.

Authors:  Kristina Hölig; Michael Kramer; Frank Kroschinsky; Martin Bornhäuser; Thilo Mengling; Alexander H Schmidt; Claudia Rutt; Gerhard Ehninger
Journal:  Blood       Date:  2009-08-07       Impact factor: 22.113

5.  Parent versus child donor perceptions of the bone marrow donation experience.

Authors:  G E Switzer; J Bruce; G Pastorek; D M Kiefer; H Kobusingye; R Drexler; R A M Besser; D L Confer; M M Horowitz; R J King; B E Shaw; S M van Walraven; L Wiener; W Packman; J W Varni; M A Pulsipher
Journal:  Bone Marrow Transplant       Date:  2017-06-26       Impact factor: 5.483

6.  Health-Related Quality of Life among Pediatric Hematopoietic Stem Cell Donors.

Authors:  Galen E Switzer; Jessica Bruce; Deidre M Kiefer; Hati Kobusingye; Rebecca Drexler; RaeAnne M Besser; Dennis L Confer; Mary M Horowitz; Roberta J King; Bronwen E Shaw; Suzanna M van Walraven; Lori Wiener; Wendy Packman; James W Varni; Michael A Pulsipher
Journal:  J Pediatr       Date:  2016-08-10       Impact factor: 4.406

7.  Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose.

Authors:  Michael A Pulsipher; Pintip Chitphakdithai; Brent R Logan; Susan F Leitman; Paolo Anderlini; John P Klein; Mary M Horowitz; John P Miller; Roberta J King; Dennis L Confer
Journal:  Blood       Date:  2009-07-16       Impact factor: 22.113

8.  Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation.

Authors:  Michael A Pulsipher; Pintip Chitphakdithai; Brent R Logan; Willis H Navarro; John E Levine; John P Miller; Bronwen E Shaw; Paul V O'Donnell; Navneet S Majhail; Dennis L Confer
Journal:  Blood       Date:  2014-04-15       Impact factor: 22.113

9.  Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually.

Authors:  J R Passweg; H Baldomero; P Bader; C Bonini; S Cesaro; P Dreger; R F Duarte; C Dufour; J Kuball; D Farge-Bancel; A Gennery; N Kröger; F Lanza; A Nagler; A Sureda; M Mohty
Journal:  Bone Marrow Transplant       Date:  2016-02-22       Impact factor: 5.483

10.  Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.

Authors:  Michael A Pulsipher; Brent R Logan; Deidre M Kiefer; Pintip Chitphakdithai; Marcie L Riches; J Douglas Rizzo; Paolo Anderlini; O'Susan F Leitman; Hati Kobusingye; RaeAnne M Besser; John P Miller; Rebecca J Drexler; Aly Abdel-Mageed; Ibrahim A Ahmed; Luke P Akard; Andrew S Artz; Edward D Ball; Ruthee-Lu Bayer; Carolyn Bigelow; Brian J Bolwell; E Randolph Broun; David C Delgado; Katharine Duckworth; Christopher C Dvorak; Theresa E Hahn; Ann E Haight; Parameswaran N Hari; Brandon M Hayes-Lattin; David A Jacobsohn; Ann A Jakubowski; Kimberly A Kasow; Hillard M Lazarus; Jane L Liesveld; Michael Linenberger; Mark R Litzow; Walter Longo; Margarida Magalhaes-Silverman; John M McCarty; Joseph P McGuirk; Shahram Mori; Vinod Parameswaran; Vinod K Prasad; Scott D Rowley; Witold B Rybka; Indira Sahdev; Jeffrey R Schriber; George B Selby; Paul J Shaughnessy; Shalini Shenoy; Thomas Spitzer; William T Tse; Joseph P Uberti; Madhuri Vusirikala; Edmund K Waller; Daniel J Weisdorf; Gregory A Yanik; Willis H Navarro; Mary M Horowitz; Galen E Switzer; Dennis L Confer; Bronwen E Shaw
Journal:  Haematologica       Date:  2018-10-31       Impact factor: 9.941

View more
  1 in total

1.  Decreased Opioid Consumption in Bone Marrow Harvest Patients Using Quadratus Lumborum Blocks in a Standardized Protocol.

Authors:  Nicole C McCoy; Ellen L Hay; Deborah A Romeo; J Wesley Doty; Bethany J Wolf; Michelle P Hudspeth
Journal:  Front Med (Lausanne)       Date:  2022-04-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.